Literature DB >> 10813751

In vitro and in vivo biocompatibility of chitosan-xanthan polyionic complex.

F Chellat1, M Tabrizian, S Dumitriu, E Chornet, P Magny, C H Rivard, L Yahia.   

Abstract

A novel hydrogel, CHITOXAN(TM) (CH-X), has potential as a vehicle for controlled drug delivery. The hydrogel is obtained by complexation of two polysaccharides, chitosan and xanthan. In the present work we investigated the biocompatibility of the complex using in vitro and in vivo models. The cytotoxic effects of CH-X microspheres as well as their degradation products at different concentrations were assessed on fibroblasts (fibroblast cell line L-929) using 3-(4,5-dimethylthiazole-2yl)-2,5-triphenyl tetrazolium) (MTT). The test is based on mitochondrial dehydrogenase cell activity as an indicator of cell viability. Interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) cytokines as well as nitric oxide (NO) production by macrophages (macrophage cell line J-774) were examined as indicators of cell activation. In vivo biocompatibility assessment was performed for 1 to 12 weeks. This study was performed using tablets obtained after compression of CH-X particles implanted at the subcutaneous level in male Wistar rats. CH-X biocompatibility and degradation were investigated using histological studies. Light and transmission electron microscopy (TEM) analyses were used to determine the foreign-body reaction and phagocytosis of the implants by macrophages. Fibroblast exposition to CH-X particles and degradation products did not show cytotoxic effects as measured by MTT test. TNF-alpha production was dependent on CH-X particles concentration, whereas IL-1beta production was found to be dose independent. CH-X extract products stimulated TNF-alpha secretion when used at the highest concentration (10 mg/mL), notably after 28 days' degradation time. No effect was observed on IL-1beta production when CH-X extracts were used in comparison to the control. The effects of CH-X particles on NO secretion were similar as on TNF-alpha. Histological studies showed that CH-X tablets broke down into particles which progressively degraded into smaller fragments. A significant fraction of the fragments was ingested by the macrophages after 12 weeks of implantation. Light microscopy studies showed a weak foreign-body reaction as a function of time and the fibrous layer thickness decreased with time of implantation. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813751     DOI: 10.1002/(sici)1097-4636(200007)51:1<107::aid-jbm14>3.0.co;2-f

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  14 in total

1.  A composite polyelectrolytic matrix for controlled oral drug delivery.

Authors:  Priya Bawa; Viness Pillay; Yahya Essop Choonara; Lisa Claire du Toit; Valence Methaius Kessy Ndesendo; Pradeep Kumar
Journal:  AAPS PharmSciTech       Date:  2011-01-12       Impact factor: 3.246

2.  A homogenous CS/NaCMC/n-HA polyelectrolyte complex membrane prepared by gradual electrostatic assembling.

Authors:  Hong Jiang; Yi Zuo; Lin Cheng; Hongli Wang; Aiqun Gu; Yubao Li
Journal:  J Mater Sci Mater Med       Date:  2010-12-08       Impact factor: 3.896

Review 3.  Chitin and chitosan: biopolymers for wound management.

Authors:  Rita Singh; Kirti Shitiz; Antaryami Singh
Journal:  Int Wound J       Date:  2017-08-10       Impact factor: 3.315

4.  Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy: Development, Characterization, and Pharmacodynamic Study.

Authors:  Parasuraman Mohan; Karthikeyan Kesavan
Journal:  AAPS PharmSciTech       Date:  2021-06-28       Impact factor: 3.246

5.  Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori.

Authors:  Saahil Arora; Sankalp Gupta; Raj K Narang; Ramji D Budhiraja
Journal:  Sci Pharm       Date:  2011-05-19

6.  Zwitterionic chitosan derivative, a new biocompatible pharmaceutical excipient, prevents endotoxin-mediated cytokine release.

Authors:  Gaurav Bajaj; William G Van Alstine; Yoon Yeo
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

7.  Synthesis and Characterization of Nanodiamond Reinforced Chitosan for Bone Tissue Engineering.

Authors:  Yu Sun; Qiaoqin Yang; Haidong Wang
Journal:  J Funct Biomater       Date:  2016-09-15

8.  Pilot Study Using a Chitosan-Hydroxyapatite Implant for Guided Alveolar Bone Growth in Patients with Chronic Periodontitis.

Authors:  Fabiola Vaca-Cornejo; Héctor Macías Reyes; Sergio H Dueñas Jiménez; Ricardo A Llamas Velázquez; Judith M Dueñas Jiménez
Journal:  J Funct Biomater       Date:  2017-07-19

Review 9.  In vitro models in biocompatibility assessment for biomedical-grade chitosan derivatives in wound management.

Authors:  Lim Chin Keong; Ahmad Sukari Halim
Journal:  Int J Mol Sci       Date:  2009-03-18       Impact factor: 6.208

10.  Xanthan gum as an adjuvant in a subunit vaccine preparation against leptospirosis.

Authors:  Katia L Bacelo; Daiane D Hartwig; Fabiana K Seixas; Rodrigo Schuch; Angelita da S Moreira; Marta Amaral; Tiago Collares; Claire T Vendrusculo; Alan J A McBride; Odir A Dellagostin
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.